ABVC offering history
Every offering-related filing in ABVC BIOPHARMA, INC.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 786 filings back to Jun 28, 2002.
| Date | Filing | What it means | |
|---|---|---|---|
| Nov 14, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Nov 14, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Nov 14, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Nov 14, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 15, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 15, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 15, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 15, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 15, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| May 22, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 20, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 20, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 30, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 6, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Nov 15, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Nov 15, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Nov 15, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Nov 15, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Nov 4, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 25, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 16, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 16, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 16, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Aug 7, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 7, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 1, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 12, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jul 1, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 21, 2024 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| May 23, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| May 23, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 22, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| May 22, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Apr 30, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 5, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Apr 1, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 22, 2024 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 16, 2024 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 9, 2024 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 8, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
ABVC offering FAQ
When did ABVC last execute an offering?
Per SEC filings, ABVC BIOPHARMA, INC.'s most recent priced offering document is a 424B4 filed 2025-11-14. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did ABVC last announce or register an offering?
The most recent registration is a S-3 filed 2025-05-22. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.